Diltiazem Hydrochloride Injection shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting 2026-01-05 · last update 2026-01-05
Manufacturers: Hospira, Inc., a Pfizer Company
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Diltiazem Hydrochloride, Injection, 100 mg Single Dose ADD-Vantage® Glass Vial (NDC 0409-4350-03) | Hospira, Inc., a Pfizer Company | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 01/05/2026 Updated 01/05/2026 Discontinued 01/05/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)